Patient-Centred Monitoring in MG – Guides to MG-ADL and MGC scoring tools

The fluctuating nature of MG symptoms makes it challenging to consistently assess disease severity and its impact on patients’ daily lives.¹

Over the past few decades multiple assessment tools have been developed to reflect clinician-reported (objective), patient-reported, and composite measures of MG disease severity.¹

Download the materials below to learn more about MG-ADL and MGC scoring tools. 

Abbreviations: MG, Myasthenia Gravis; MG-ADL, Myasthenia Gravis Activities of Daily Living; MGC, Myasthenia Gravis Composite.

Reference: 1. Thomsen JLS, Andersen H. Front Neurol. 2020;11:596382

February 2026. AU-RZ-2600011